ALINA VRINCEANU-HAMM: Open Payments
NPI 1790729028 · PRINCETON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 49 payments from 11 companies in 2025. Trend: 2023 $764 · 2024 $737 · 2025 $858
Food & beverage: $731Education: $126
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $225 |
| ABBVIE INC. | 15 | $155 |
| Lundbeck LLC | 5 | $126 |
| Janssen Pharmaceuticals, Inc | 5 | $92 |
| Braeburn Inc. | 3 | $69 |
| Alkermes, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Indivior Inc. | 1 | $20 |
Products named: VRAYLAR, AUSTEDO XR, ABILIFY MAINTENA, INVEGA SUSTENNA, BRIXADI, VIVITROL, COBENFY, INGREZZA.
Industry payments across WV — which companies pay providers there.
